search
fentanyl
Trends
- 1New guidance targets dangerous 'rhino tranq' withdrawal▼New guidance targets dangerous ‘rhino tranq’ withdrawal
New clinical guidance has been issued on treating withdrawal from xylazine, the animal sedative increasingly found mixed into illicit opioids and nicknamed the 'rhino tranq'. Unlike opioid withdrawal, xylazine withdrawal can be severe and difficult to manage with standard treatments, and the guidance aims to give clinicians a clearer approach as the drug spreads in the fentanyl supply.